These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32375056)

  • 1. The Extent of Extended-Ubiquitin Binding to the Proteasome.
    Roelofs J
    Structure; 2020 May; 28(5):489-491. PubMed ID: 32375056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Extended Conformation for K48 Ubiquitin Chains Revealed by the hRpn2:Rpn13:K48-Diubiquitin Structure.
    Lu X; Ebelle DL; Matsuo H; Walters KJ
    Structure; 2020 May; 28(5):495-506.e3. PubMed ID: 32160516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome.
    Chen X; Randles L; Shi K; Tarasov SG; Aihara H; Walters KJ
    Structure; 2016 Aug; 24(8):1257-1270. PubMed ID: 27396824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of Poly-Ubiquitins by the Proteasome through Protein Refolding Guided by Electrostatic and Hydrophobic Interactions.
    Zhang Y; Vuković L; Rudack T; Han W; Schulten K
    J Phys Chem B; 2016 Aug; 120(33):8137-46. PubMed ID: 27012670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Ubiquitin Linkage-type Analysis Reveals that the Cdc48-Rad23/Dsk2 Axis Contributes to K48-Linked Chain Specificity of the Proteasome.
    Tsuchiya H; Ohtake F; Arai N; Kaiho A; Yasuda S; Tanaka K; Saeki Y
    Mol Cell; 2017 May; 66(4):488-502.e7. PubMed ID: 28525741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for the Inhibitory Effects of Ubistatins in the Ubiquitin-Proteasome Pathway.
    Nakasone MA; Lewis TA; Walker O; Thakur A; Mansour W; Castañeda CA; Goeckeler-Fried JL; Parlati F; Chou TF; Hayat O; Zhang D; Camara CM; Bonn SM; Nowicka UK; Krueger S; Glickman MH; Brodsky JL; Deshaies RJ; Fushman D
    Structure; 2017 Dec; 25(12):1839-1855.e11. PubMed ID: 29153505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR reveals a different mode of binding of the Stam2 VHS domain to ubiquitin and diubiquitin.
    Lange A; Hoeller D; Wienk H; Marcillat O; Lancelin JM; Walker O
    Biochemistry; 2011 Jan; 50(1):48-62. PubMed ID: 21121635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate degradation by the proteasome: a single-molecule kinetic analysis.
    Lu Y; Lee BH; King RW; Finley D; Kirschner MW
    Science; 2015 Apr; 348(6231):1250834. PubMed ID: 25859050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the Structural and Dynamic Nature of the Ubiquitin Code.
    Di Lello P; Hymowitz SG
    Structure; 2016 Apr; 24(4):498-499. PubMed ID: 27050685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of substrates to the 26S proteasome.
    Pickart CM
    FASEB J; 1997 Nov; 11(13):1055-66. PubMed ID: 9367341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hydrophobic effect contributes to polyubiquitin chain recognition.
    Beal RE; Toscano-Cantaffa D; Young P; Rechsteiner M; Pickart CM
    Biochemistry; 1998 Mar; 37(9):2925-34. PubMed ID: 9485444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rpn10 protects the proteasome from Dsk2.
    Walters KJ; Zhang N
    Mol Cell; 2008 Nov; 32(4):459-60. PubMed ID: 19026775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Snapshots of 26S Proteasome Reveal Tetraubiquitin-Induced Conformations.
    Ding Z; Xu C; Sahu I; Wang Y; Fu Z; Huang M; Wong CCL; Glickman MH; Cong Y
    Mol Cell; 2019 Mar; 73(6):1150-1161.e6. PubMed ID: 30792173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional differences between two major ubiquitin receptors in the proteasome; S5a and hRpn13.
    Elangovan M; Oh C; Sukumaran L; Wójcik C; Yoo YJ
    Biochem Biophys Res Commun; 2010 May; 396(2):425-8. PubMed ID: 20417181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome.
    Shi Y; Chen X; Elsasser S; Stocks BB; Tian G; Lee BH; Shi Y; Zhang N; de Poot SA; Tuebing F; Sun S; Vannoy J; Tarasov SG; Engen JR; Finley D; Walters KJ
    Science; 2016 Feb; 351(6275):. PubMed ID: 26912900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin receptor proteins hHR23a and hPLIC2 interact.
    Kang Y; Zhang N; Koepp DM; Walters KJ
    J Mol Biol; 2007 Jan; 365(4):1093-101. PubMed ID: 17098253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient kinetic analysis of USP2-catalyzed deubiquitination reveals a conformational rearrangement in the K48-linked diubiquitin substrate.
    Bozza WP; Liang Q; Gong P; Zhuang Z
    Biochemistry; 2012 Dec; 51(50):10075-86. PubMed ID: 23211065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-species divergence of the major recognition pathways of ubiquitylated substrates for ubiquitin/26S proteasome-mediated proteolysis.
    Fatimababy AS; Lin YL; Usharani R; Radjacommare R; Wang HT; Tsai HL; Lee Y; Fu H
    FEBS J; 2010 Feb; 277(3):796-816. PubMed ID: 20059542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.
    Qiu XB; Ouyang SY; Li CJ; Miao S; Wang L; Goldberg AL
    EMBO J; 2006 Dec; 25(24):5742-53. PubMed ID: 17139257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets.
    Lu X; Nowicka U; Sridharan V; Liu F; Randles L; Hymel D; Dyba M; Tarasov SG; Tarasova NI; Zhao XZ; Hamazaki J; Murata S; Burke TR; Walters KJ
    Nat Commun; 2017 Jun; 8():15540. PubMed ID: 28598414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.